Who owns OCUPHIRE PHARMA INC?
- Ticker: IRD
- CUSIP Number: 67577r102
Tip: Access positions for across all investors
Analyze quarterly positions in Ocuphire Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ocuphire Pharma stock
Who bought or sold OCUPHIRE PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Nantahala Capital Management | 4.8M | $9.6M | 43% | Dec 2025 |
|
| Perceptive Advisors | 4.3M | $7.1M | 0% | Sep 2025 |
|
| BIOS Capital Management | 3.7M | $7.4M | 0% | Dec 2025 |
|
| Vanguard Group | 2.3M | $4.7M | 73% | Dec 2025 |
|
| Mink Brook Asset Management | 1.7M | $3.3M | 35% | Dec 2025 |
|
| Opaleye Management | 1.1M | $2.3M | 2% | Dec 2025 |
|
| Adage Capital Partners GP | 955k | $1.6M | 100% | Sep 2025 |
|
| Bleichroeder | 737k | $1.5M | 0% | Dec 2025 |
|
| Geode Capital Management | 505k | $1.0M | 8% | Dec 2025 |
|
| Voss Capital | 442k | $888k | -21% | Dec 2025 |
|
| Susquehanna International | 248k | $498k | 1126% | Dec 2025 |
|
| Wells Fargo & Company | 242k | $486k | 6290% | Dec 2025 |
|
| State Street Corporation | 173k | $348k | 19% | Dec 2025 |
|
| Marshall Wace | 158k | $317k | 100% | Dec 2025 |
|
| BlackRock | 142k | $285k | 208% | Dec 2025 |
|
| Creative Planning | 128k | $258k | 0% | Dec 2025 |
|
| Renaissance Technologies | 126k | $254k | -27% | Dec 2025 |
|
| Citadel Advisors | 113k | $187k | 497% | Sep 2025 |
|
| Two Sigma Investments | 108k | $179k | 170% | Sep 2025 |
|
| UBS Group | 90k | $181k | 10060% | Dec 2025 |
|
| OMERS Administration Corporation | 88k | $177k | 100% | Dec 2025 |
|
| Northern Trust | 87k | $176k | 28% | Dec 2025 |
|
| Texas Capital Bank Wealth Management Services | 78k | $157k | 100% | Dec 2025 |
|
| Regency Capital Management | 46k | $93k | 100% | Dec 2025 |
|
| Empowered Funds | 42k | $85k | 0% | Dec 2025 |
|
| Bridgeway Capital Management | 42k | $69k | 0% | Sep 2025 |
|
| ADAR1 Capital Management | 40k | $80k | 100% | Dec 2025 |
|
| Qube Research & Technologies | 40k | $80k | 100% | Dec 2025 |
|
| Captrust Financial Advisors | 32k | $64k | 0% | Dec 2025 |
|
| William Blair $ Company | 25k | $40k | 0% | Sep 2025 |
|
| XTX Topco | 24k | $48k | -54% | Dec 2025 |
|
| Raymond James Financial | 21k | $41k | -9% | Dec 2025 |
|
| Johnson Investment Counsel | 20k | $40k | 100% | Dec 2025 |
|
| Virtu Financial | 17k | $34k | 100% | Dec 2025 |
|
| James Investment Research | 16k | $33k | 0% | Dec 2025 |
|
| Goss Wealth Management | 16k | $33k | 0% | Dec 2025 |
|
| Kestra Private Wealth Services | 16k | $32k | -16% | Dec 2025 |
|
| Bedel Financial Consulting | 15k | $30k | 0% | Dec 2025 |
|
| Advisor Group Holdings | 14k | $28k | 0% | Dec 2025 |
|
| Occudo Quantitative Strategies | 12k | $25k | 100% | Dec 2025 |
|
| Stokes Family Office | 12k | $24k | 0% | Dec 2025 |
|
| Brian McDonald | 12k | $24k | 0% | Dec 2025 |
|
| First City Capital Management | 12k | $24k | 100% | Dec 2025 |
|
| Two Sigma Advisers | 10k | $17k | 100% | Sep 2025 |
|
| Reliant Investment Partners | 10k | $20k | 0% | Dec 2025 |
|
| Annandale Capital | 10k | $20k | 0% | Dec 2025 |
|
| Miller Financial Services | 10k | $20k | 100% | Dec 2025 |
|
| Simplex Trading | 9.1k | $18k | -72% | Dec 2025 |
|
| SBI Securities | 2.6k | $5.2k | 0% | Dec 2025 |
|
| National Bank Of Canada /fi/ | 2.0k | $4.0k | 0% | Dec 2025 |
|
| Barclays | 1.9k | $3.8k | 0% | Dec 2025 |
|
| International Assets Investment Management | 521.00 | $1.0k | 100% | Dec 2025 |
|
| Royal Bank of Canada | 30.00 | $0 | -100% | Sep 2025 |
|
| Hanson McClain Advisors | 5.00 | $11.000000 | 100% | Dec 2025 |
|
Who sold out of Ocuphire Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Millennium Management | Jun 2025 | 128k | $120k |
| Hrt Financial | Sep 2025 | 21k | $34k |
| Two Sigma Securities | Sep 2025 | 18k | $29k |
| Prudential Financial | Sep 2025 | 13k | $22k |
| MAI Wealth Advisors | Sep 2025 | 123.00 | $202.999200 |